Chemotherapy: Multicombination Approach Suppresses Listeria monocytogenes‐Induced Septicemia‐Associated Acute Hepatic Failure: The Role of iRhom2 Signaling (Adv. Healthcare Mater. 17/2018)

Biomaterials functionalized with nano‐scale drug carriers exhibit excellent biological properties. In article 1800427, a novel design by Min‐Xuan Xu, Jun Tan, and co‐workers, highlights the latest advanced approach regarding the multicombination drug delivery for the chemoprevention of septicemia‐as...

Full description

Saved in:
Bibliographic Details
Published in:Advanced healthcare materials 2018-09, Vol.7 (17), p.n/a
Main Authors: Xu, Min‐Xuan, Ge, Chen‐Xu, Qin, Yu‐Ting, Gu, Ting‐Ting, Lou, De‐Shuai, Li, Qiang, Hu, Lin‐Feng, Tan, Jun
Format: Article
Language:English
Subjects:
Biological properties
Biomaterials
Biomedical materials
Chemotherapy
Drug carriers
Drug delivery
Drug delivery systems
Drug development
fisetin
FN nanoparticles
Inflammation
Inflammatory response
iRhom2
Listeria
Listeria monocytogenes
Liver
Nanoparticles
Oxidative stress
Sepsis
Septicemia
Systemic inflammatory response syndrome
Workers
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Biomaterials functionalized with nano‐scale drug carriers exhibit excellent biological properties. In article 1800427, a novel design by Min‐Xuan Xu, Jun Tan, and co‐workers, highlights the latest advanced approach regarding the multicombination drug delivery for the chemoprevention of septicemia‐associated acute hepatic failure. The multifunctional nanoparticles can effectively suppress septicemia, systemic inflammatory response syndrome, and corresponding fatal hepatic injury by inhibition of oxidative stress and inflammation.
ISSN:2192-2640
2192-2659
DOI:10.1002/adhm.201870068